Results 301 to 310 of about 406,081 (396)

Sex-specific trends in the global burden and risk factors of atrial fibrillation and flutter from 1990 to 2021. [PDF]

Sci Rep
Peng X, Wang J, Tang C, He L, Li J, Xia S, Kong X, Zhou N, Long D, Sang C, Du X, Dong J, Ma C.   +12 more
europepmc   +1 more source

A Case of Immediate Reduction of Severe Mitral Regurgitation After the Ablation of Atrial Flutter. [PDF]

Cureus
Eldawud D, Saeidifard F, Abdulfattah AY, Nakadar Z, Gupta T, Weinstock M, Mitre CA.   +6 more
europepmc   +1 more source

Clinical insights into the role of bepridil in recurrence prevention after ablation of persistent atrial fibrillation

Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
This retrospective study included 232 consecutive persistent atrial fibrillation patients according to the inclusion criteria. Despite patients characteristics with more severe atrial substrates in the Bepridil group, Kaplan–Meier curves showed no significant difference in the AF/AT freedom rate and clinical adverse events between the Bepridil and No ...
Moyuru Hirata, Koichi Nagashima, Ryuta Watanabe, Yuji Wakamatsu, Naoto Otsuka, Shu Hirata, Masanaru Sawada, Yuji Saito, Sayaka Kurokawa, Kenta Murotani, Yasuo Okumura   +10 more
wiley   +1 more source

Pulsed field ablation of refractory alternating atrial fibrillation and atrial flutter using Impella CP in a patient with cardiogenic shock: a case report. [PDF]

Eur Heart J Case Rep
Rattka I, Mastella G, Martens E, Laugwitz KL, Rattka M.   +4 more
europepmc   +1 more source

Accuracy and interpretability of smartwatch electrocardiogram for early detection of atrial fibrillation: A systematic review and meta‐analysis

Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
The smartwatch ECG algorithm achieved 86% sensitivity and 94% specificity with an sAUC of 96%, while manual readings by trained personnel reached 96% sensitivity, 95% specificity, and an sAUC of 98% in a brand‐specific subgroup analysis. These findings demonstrate that the smartwatch ECG detects AFib, although 3% of results are unreadable.
Muhammad Iqhrammullah, Asnawi Abdullah, Hermansyah, Fahmi Ichwansyah, Hafnidar A. Rani, Meulu Alina, Artha M. T. Simanjuntak, Derren D. C. H. Rampengan, Seba Talat Al‐Gunaid, Naufal Gusti, Arditya Damarkusuma, Edza Aria Wikurendra   +11 more
wiley   +1 more source

Body surface mapping of counterclockwise and clockwise typical atrial flutter: a comparative analysis with endocardial activation sequence mapping

, 2000
A. SippensGroenewegen, Michael D. Lesh, Franz Xaver Roithinger, Willard S. Ellis, P. Steiner, Leslie A. Saxon, Randall J. Lee, Melvin M. Scheinman   +7 more
openalex   +1 more source

Author Correction: Sex-specific trends in the global burden and risk factors of atrial fibrillation and flutter from 1990 to 2021. [PDF]

Sci Rep
Peng X, Wang J, Tang C, He L, Li J, Xia S, Kong X, Zhou N, Long D, Sang C, Du X, Dong J, Ma C.   +12 more
europepmc   +1 more source

Checking Ablation Lines-Is Bidirectional Block Sufficient? [PDF]

J Innov Card Rhythm Manag
Weyand S, Löbig S, Seizer P.
europepmc   +1 more source

Comparing Comorbidity Indices to Predict Survival After Pediatric Hematopoietic Stem Cell Transplantation for Nonmalignant Disease

Pediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Background Hematopoietic stem cell transplantation (HCT) is a potentially curative treatment for children with hematological or immunological disorders. However, treatment‐related morbidity and mortality remain concerning. Various comorbidity indices are currently used to assess the risk of complications following pediatric HCT.
Roos Lotte Alexandra Bukman, Anne B. Verbeek, Arjan C. Lankester, Erik G. J. von Asmuth, Emilie Pauline Buddingh   +4 more
wiley   +1 more source

A Comparative Analysis of Cardiovascular Events Associated With Acalabrutinib Versus Ibrutinib in Chronic Lymphocytic Leukemia: Insights From a Global Federated Network

Pharmacology Research &Perspectives, Volume 13, Issue 3, June 2025.
ABSTRACT Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults, characterized by the accumulation of dysfunctional lymphocytes. Ibrutinib, a first‐generation Bruton tyrosine kinase (BTK) inhibitor, has significantly improved CLL treatment but is associated with adverse cardiovascular events such as atrial fibrillation (AF ...
Abdulrahman Majrashi, Ying X. Gue, Alena Shantsila, Stella Williams, Catrin Tudur Smith, Gregory Y. H. Lip, Andrew R. Pettitt   +6 more
wiley   +1 more source